Medipharm Labs Corp Stock Market Value
MEDIF Stock | USD 0.04 0 4.26% |
Symbol | Medipharm |
Medipharm Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medipharm Labs' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medipharm Labs.
01/01/2025 |
| 03/02/2025 |
If you would invest 0.00 in Medipharm Labs on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Medipharm Labs Corp or generate 0.0% return on investment in Medipharm Labs over 60 days. Medipharm Labs is related to or competes with Flora Growth, Bionoid Pharma, and C21 Investments. MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates,... More
Medipharm Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medipharm Labs' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medipharm Labs Corp upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.01) | |||
Maximum Drawdown | 19.9 | |||
Value At Risk | (7.80) | |||
Potential Upside | 8.33 |
Medipharm Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medipharm Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medipharm Labs' standard deviation. In reality, there are many statistical measures that can use Medipharm Labs historical prices to predict the future Medipharm Labs' volatility.Risk Adjusted Performance | (0.0003) | |||
Jensen Alpha | (0.08) | |||
Total Risk Alpha | 0.0801 | |||
Treynor Ratio | 0.077 |
Medipharm Labs Corp Backtested Returns
At this point, Medipharm Labs is out of control. Medipharm Labs Corp has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Medipharm Labs, which you can use to evaluate the volatility of the firm. Please verify Medipharm Labs' Standard Deviation of 4.63, risk adjusted performance of (0.0003), and Mean Deviation of 3.63 to check out if the risk estimate we provide is consistent with the expected return of 0.0017%. The company secures a Beta (Market Risk) of -0.84, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Medipharm Labs are expected to decrease at a much lower rate. During the bear market, Medipharm Labs is likely to outperform the market. Medipharm Labs Corp right now secures a risk of 4.69%. Please verify Medipharm Labs Corp skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if Medipharm Labs Corp will be following its current price movements.
Auto-correlation | 0.47 |
Average predictability
Medipharm Labs Corp has average predictability. Overlapping area represents the amount of predictability between Medipharm Labs time series from 1st of January 2025 to 31st of January 2025 and 31st of January 2025 to 2nd of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medipharm Labs Corp price movement. The serial correlation of 0.47 indicates that about 47.0% of current Medipharm Labs price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.47 | |
Spearman Rank Test | 0.22 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Medipharm Labs Corp lagged returns against current returns
Autocorrelation, which is Medipharm Labs otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medipharm Labs' otc stock expected returns. We can calculate the autocorrelation of Medipharm Labs returns to help us make a trade decision. For example, suppose you find that Medipharm Labs has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Medipharm Labs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medipharm Labs otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medipharm Labs otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medipharm Labs otc stock over time.
Current vs Lagged Prices |
Timeline |
Medipharm Labs Lagged Returns
When evaluating Medipharm Labs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medipharm Labs otc stock have on its future price. Medipharm Labs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medipharm Labs autocorrelation shows the relationship between Medipharm Labs otc stock current value and its past values and can show if there is a momentum factor associated with investing in Medipharm Labs Corp.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Medipharm OTC Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.